Operational Utility

• qXR : The "Junior Radiologist" for X-rays. It detects 30+ findings (Lung Nodules, Pleural Effusions, Cardiomegaly) in <10 seconds.
  • Urgent Care Use Case: A nurse practitioner in a rural clinic takes an X-ray. qXR instantly flags "Suspected Pneumonia," allowing them to prescribe antibiotics confidently without waiting 4 hours for a radiologist's remote read.
• The qER Stroke Care Suite:
  • Complete Triage: It doesn't just find bleeds. It is a full "Hub-and-Spoke" platform including LVO Detection (Large Vessel Occlusion on CTA), Automated ASPECTS scoring (to assess stroke severity), and Bleed Quantification (measuring hemorrhage volume for surgery planning).
  • Mobile App: Like Viz.ai, it includes a secure mobile app that alerts the entire stroke team (Interventionalists, ER, Neuro) instantly, allowing them to view scans and coordinate transfers from "Spoke" hospitals.
• qER (Trauma & Fracture): Beyond stroke, it is a trauma safety net. It detects cranial fractures, midline shift, and mass effect on non-contrast CTs, prioritizing these "Red Flag" patients on the radiologist’s worklist.
• qTrack (Lung Cancer Management): Tracks lung nodules over time. If a patient returns 6 months later, it automatically calculates the "Volume Doubling Time" to flag malignancy risk to the Pulmonologist.
• TB Screening: The global standard (WHO-endorsed) for automated Tuberculosis screening in public health programs.

The "Trust" Profile (Compliance & Security)

• HIPAA Compliant: Yes.
• FDA Status: Cleared (19+ Clearances).
  • The Record Breaker: As of late 2025, they hold one of the highest numbers of FDA clearances in the industry.
  • Key Clearances: qXR (Chest X-Ray abnormalities), qER (Brain Bleed/Fracture), qCT-Lung (Nodule quantization), and recently qER-CTA (Large Vessel Occlusion for Stroke).
• Global Validation: Unlike US-only AI, Qure is battle-tested on 40+ million scans across 80 countries. It works on "noisy" images from old X-ray machines in emerging markets, making it incredibly robust compared to AI trained only on pristine academic hospital data.
• Security: SOC 2 Type II and ISO 27001.

Implementation & Integrations

• Access Method: Flexible.
  • Cloud: Sends images to Qure’s cloud (most common).
  • Edge Box: A physical box that sits next to the X-ray machine (for clinics with bad internet).
• Integrations: Deep partnerships with Fujifilm, AstraZeneca, and Siemens. Often, qXR comes "pre-installed" on new portable X-ray machines.
• Teleradiology Sync: It integrates with vRad and other teleradiology platforms to "pre-read" cases before they hit the human doctor's screen.

Pricing Model

• Structure: Per-Click (Volume) or Annual License.
• The "Urgent Care" Model: Qure.ai is often friendlier to smaller networks, offering per-scan pricing or lower-tier licensing for outpatient clinics.
• Commercial Partners: Pharmaceutical companies (like AstraZeneca) sometimes subsidize the cost of Qure.ai for health systems to improve lung cancer detection rates (since finding more cancer = more patients eligible for their drugs).

The Doxiverse Assessment: Risks & Limitations

• The Strategic Upside: Catching the "Misses." The naked eye misses ~20-30% of small lung nodules on X-rays. qXR acts as a "spell check," finding early-stage cancers that would otherwise be ignored until they reached Stage 4.
• The "Workflow" Friction: In US hospitals, doctors rely on CTs, not X-rays, for serious diagnostics. qXR is less valuable in a Level 1 Trauma Center (where everyone gets a CT) than in an Urgent Care (where X-ray is the only tool).
• Over-Sensitivity: Like all CAD tools, it hates to miss cancer. It may flag benign rib shadows as "Nodules," leading to unnecessary follow-up CT scans. This "Cascade of Care" can be expensive for patients.

Qure.ai vs. Viz.ai (Stroke)

• Viz.ai is still the "Perfusion First" king (CTP). If your center relies heavily on CT Perfusion maps to make thrombectomy decisions, Viz is the incumbent standard.
• Qure.ai is the "NCCT First" challenger. If your stroke protocol relies more on Non-Contrast CT (ASPECTS) and CTA (LVO)—which is common in Europe and many US centers moving away from universal perfusion—Qure offers a very competitive, often more affordable, alternative.

Ideal User Profile

• Perfect For: Urgent Care Chains, Rural Critical Access Hospitals, and Public Health Departments (TB clinics).

Disclaimer

AI tools evolve daily. The features, pricing, and compliance status listed above are based on publicly available information. Vendors may update capabilities without notice. Always verify information directly with the vendor before implementation.

Doxiverse provides operational software analysis, not medical advice. The decision to use a clinical tool rests solely with the licensed provider. We are not liable for clinical errors resulting from the use of these tools.